Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
53. (KR1020050042157) CANNABINOID LIQUID FORMULATIONS FOR MUCOSAL AMDINISTRATION

Application Number: 1020057002528 Application Date: 14.02.2005
Publication Number: 1020050042157 Publication Date: 04.05.2005
Publication Kind : A
IPC:
A61K 9/12
A61K 31/352
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
12
Aerosols; Foams
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
35
having six-membered rings with one oxygen as the only ring hetero atom
352
condensed with carbocyclic rings, e.g. cannabinols, methantheline
CPC:
A61K 9/006
Applicants: GW PHARMA LIMITED
지더블유 파마 리미티드
Inventors: WHITTLE BRIAN ANTHONY
휘틀, 브라이언 앤쏘니
Agents: 김영호
Priority Data: 0218930.6 14.08.2002 GB
01/218.989 14.08.2002 US
Title: (EN) CANNABINOID LIQUID FORMULATIONS FOR MUCOSAL AMDINISTRATION
(KO) 점막투여용 칸나비노이드 액체 제형
Abstract:
(EN)

The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray. In particular, the invention relates to pharmaceutical formulations, for use in administration of lipophilic medicaments comprising one or more cannabinoids via mucosal surfaces, comprising: at least one lipophilic medicament which comprises one or more cannabinoids, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55 % wt/wt of the formulation, the formulation is absent of a self emulsifying agent and/or a fluorinated propellant, and the cannabinoid(s) is/are present in the formulation in an amount greater than 10 mg/ml.

© KIPO & WIPO 2007


(KO) 본 발명은 약제학적 제형 및 더욱 특히 펌프작용 스프레이에 의해 투여하기 위한 칸나비노이드 함유 제형에 관한 것이다. 특히 본 발명은 하나 이상의 칸나비노이드를 포함한 친유성 약제, 용매 및 공용매를 포함하는, 점막표면을 거쳐 하나 이상의 칸나비노이드를 포한하는 친유성 약제의 투여에 사용되며, 제형중에 존재하는 용매와 공용매의 총량이 제형의 55중량% 이상이고, 제형이 자기 유화제 및/또는 불화 추진제를 함유하지 않으며, 칸나비노이드가 10mg/ml 이상의 량으로 제형 중에 존재하는 액체 약제학적 제형에 관한 것이다.